Yes, immunotherapy treatments are among the most expensive therapeutic options available in modern medicine, often costing tens or hundreds of thousands of dollars per year. The high price tag is driven by complex biotechnology manufacturing processes, extensive research and clinical development expenses, specialized administration requirements, and intensive post-treatment patient monitoring protocols managed by specialized oncology care teams.